Trustee purchases a total of 242,000 shares under the stock incentive plan for SAINT BELLA GP(02508).
The Saint Bella Group (02508) announced that from May 7, 2026 to May 18, 2026, the trustee has purchased a total of 242,000 shares in the market according to the Saint Bella 2025 share award plan, with an average transaction price of approximately HK$3.87 per share, and a total transaction amount of approximately HK$935,000. As of the date of this announcement, the trustee has purchased a total of 5.401 million shares in the market, with a total transaction amount of approximately HK$22.719 million.
SAINT BELLA GP(02508) announced that from May 7, 2026 to May 18, 2026, the trustee purchased a total of 242,000 shares on the market under the Saint Bella 2025 Stock Incentive Plan, with an average trading price of approximately HK$3.87 per share, with a total transaction amount of approximately HK$935,000. As of the date of this announcement, the trustee has purchased a total of 5,401,000 shares on the market, with a total transaction amount of approximately HK$22,719,000.
Related Articles
AIM VACCINE (06660): Wen Jie Resigns as Independent Non-executive Director.
CH BIOTECH SER (08037) intends to sell the entire equity of Standard Pathology Laboratory and Jockey Health for a total of HK$3.5 million
Planned acquisition of 39% equity of Heilongjiang Agriculture Reclamation Agricultural Machinery and Equipment by the First Tractor for a total of 19.7925 million yuan in 1979
AIM VACCINE (06660): Wen Jie Resigns as Independent Non-executive Director.
CH BIOTECH SER (08037) intends to sell the entire equity of Standard Pathology Laboratory and Jockey Health for a total of HK$3.5 million
Planned acquisition of 39% equity of Heilongjiang Agriculture Reclamation Agricultural Machinery and Equipment by the First Tractor for a total of 19.7925 million yuan in 1979
